home All News open_in_new Full Article

OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI

Poster Presentations featuring the latest advancements on anti-TROP2 ADCs (OBI 992 and OBI 902), AKR1C3 prodrug (OBI-3424), OBI’s novel ADC enabling technologies (GlycOBI® and ThiOBI®), and Globo H science TAIPEI, Taiwan, April 23, 2025 (GLOBE NEWSWIRE) — OBI Pharma, Inc. (TPEx: 4174. TWO) today announced nonclinical data for OBI-902, a potential best-in-class anti-TROP2 ADC developed […]


today 6 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Other
attach_file Events
attach_file Culture
attach_file Politics
attach_file Other


ID: 3232855515
Add Watch Country

arrow_drop_down